1. Home
  2. ASND vs UHS Comparison

ASND vs UHS Comparison

Compare ASND & UHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASND
  • UHS
  • Stock Information
  • Founded
  • ASND 2006
  • UHS 1978
  • Country
  • ASND Denmark
  • UHS United States
  • Employees
  • ASND N/A
  • UHS N/A
  • Industry
  • ASND Biotechnology: Pharmaceutical Preparations
  • UHS Hospital/Nursing Management
  • Sector
  • ASND Health Care
  • UHS Health Care
  • Exchange
  • ASND Nasdaq
  • UHS Nasdaq
  • Market Cap
  • ASND 10.6B
  • UHS 10.9B
  • IPO Year
  • ASND 2015
  • UHS N/A
  • Fundamental
  • Price
  • ASND $205.91
  • UHS $190.17
  • Analyst Decision
  • ASND Strong Buy
  • UHS Hold
  • Analyst Count
  • ASND 16
  • UHS 14
  • Target Price
  • ASND $240.75
  • UHS $214.46
  • AVG Volume (30 Days)
  • ASND 510.4K
  • UHS 707.1K
  • Earning Date
  • ASND 08-07-2025
  • UHS 10-23-2025
  • Dividend Yield
  • ASND N/A
  • UHS 0.42%
  • EPS Growth
  • ASND N/A
  • UHS 39.27
  • EPS
  • ASND N/A
  • UHS 18.95
  • Revenue
  • ASND $576,332,355.00
  • UHS $16,460,285,000.00
  • Revenue This Year
  • ASND $101.37
  • UHS $9.65
  • Revenue Next Year
  • ASND $76.17
  • UHS $4.89
  • P/E Ratio
  • ASND N/A
  • UHS $10.03
  • Revenue Growth
  • ASND 54.50
  • UHS 9.61
  • 52 Week Low
  • ASND $111.09
  • UHS $152.33
  • 52 Week High
  • ASND $207.00
  • UHS $243.25
  • Technical
  • Relative Strength Index (RSI)
  • ASND 68.12
  • UHS 70.39
  • Support Level
  • ASND $195.00
  • UHS $180.10
  • Resistance Level
  • ASND $203.59
  • UHS $183.05
  • Average True Range (ATR)
  • ASND 6.41
  • UHS 3.07
  • MACD
  • ASND 0.27
  • UHS 0.51
  • Stochastic Oscillator
  • ASND 93.94
  • UHS 95.14

About ASND Ascendis Pharma A/S

Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.

About UHS Universal Health Services Inc.

Universal Health Services Inc owns and operates acute care hospitals, behavior health centers, surgical hospitals, ambulatory surgery centers, and radiation oncology centers. The firm operates in two segments: Acute Care Hospital Services and Behavioral Health Services. The company generates the majority of its revenue from the Acute Care Hospital Services segment. The Acute Care Hospital Services segment includes the firm's acute care hospitals, surgical hospitals, and surgery and oncology centers.

Share on Social Networks: